Saturday, July 11, 2026

biotech · Coronary Artery Disease

Medtronic Trading NL

Medtronic BioPharma is a biotech organization headquartered in EU. Primary therapeutic focus areas include Coronary Artery Disease. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to

NL HQ
9 Employees
EMA registrant Type
Company details
Status
Public
HQ
NL
Employees
9
Programs
1
Drugs
0
Patents
0

Quick answer

Medtronic BioPharma is a biotech organization headquartered in EU. Primary therapeutic focus areas include Coronary Artery Disease. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (1).

Company snapshot

Medtronic Trading NL B.V. is a medical devices company based out of EINDHOVEN, Netherlands.

  • 1 active pipeline program(s) linked via ClinicalTrials.gov.
  • 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Medtronic Trading NL. Not investment advice.

Top assets

Lead pipeline drugs

Active clinical programs

Momentum signals

Momentum

Proprietary activity score for Medtronic Trading NL.

1 active signal

7 /100 +0 vs 30 days ago

Signal breakdown

  • Clinical trials 1 30d
  • Nova articles 0 30d
  • Patents filed 0 30d
  • FDA actions 0 30d
  • SEC filings 0 30d
  • Conference presentations 0 90d
  • Pipeline advances 0 30d
Competitive landscape
Recent activity

Recent activity

Latest pipeline, patent, and corporate events for Medtronic Trading NL.

  1. Clinical update

    Coronary Artery Stenting — Phase 2

View all clinical trial activity →

Quick answers

Common questions about this sponsor — for analysts and search.

  • What is Medtronic Trading NL?

    Medtronic BioPharma is a biotech organization headquartered in EU. Primary therapeutic focus areas include Coronary Artery Disease. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and U

  • Is Medtronic Trading NL publicly traded?

    Medtronic Trading NL appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

  • What drugs does Medtronic Trading NL develop or market?

    No drug profiles are currently linked to Medtronic Trading NL. Pipeline programs may still list investigational assets.

  • What are the latest developments for Medtronic Trading NL?

    In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

  • What therapeutic areas does Medtronic Trading NL focus on?

    Medtronic Trading NL focuses on Coronary Artery Disease based on our analysis of their pipeline programs and drug development activities.

Therapeutic focus

Therapeutic area distribution

Pipeline concentration by therapeutic area from linked clinical programs.

Programs by therapeutic area

Others
2